American Century Companies
LFCR icon

American Century Companies’s Lifecore Biomedical LFCR Stock Holding History

American Century Companies’s Portfolio LFCR Stock Details LFCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-14,481
Closed -$71.4K – 2927
2024
Q3 		$71.4K Sell
14,481
-17,501
-55% -$91.4K ﹤0.01% 2850
2024
Q2 		$164K Sell
31,982
-27,513
-46% -$163K ﹤0.01% 2763
2024
Q1 		$316K Buy
59,495
+3,775
+7% +$27K ﹤0.01% 2625
2023
Q4 		$345K Sell
55,720
-1,483
-3% -$10.3K ﹤0.01% 2506
2023
Q3 		$432K Buy
57,203
+41,625
+267% +$380K ﹤0.01% 2324
2023
Q2 		$151K Buy
+15,578
New +$95.1K ﹤0.01% 2597

Other funds holding LFCR

WC
Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return
LPAM
Legion Partners Asset Management Los Angeles, California $138M AUM 53.69% 1-Year Est. Return
2L
22NW LP Seattle, Washington $146M AUM 29.83% 1-Year Est. Return
GRIM
Greenhaven Road Investment Management Greenwich, Connecticut $145M AUM 13.76% 1-Year Est. Return
3C
325 Capital New York $274M AUM 49.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

American Century Companies's LFCR Position: Q4 2024 in Review

American Century Companies sold out of Lifecore Biomedical (LFCR) in Q4 2024, closing a stake of 14,481 shares — an estimated $71.4K sold.

American Century Companies first reported a position in LFCR in Q2 2023 and held it in 6 quarters. The position peaked at $432K in Q3 2023. 77 funds tracked by Wall St. Rank hold LFCR as of Q4 2024.

  • American Century Companies reported no remaining Lifecore Biomedical position as of Q4 2024 after selling out during the quarter.
  • American Century Companies sold 14,481 Lifecore Biomedical shares in Q4 2024, an estimated $71.4K.
  • American Century Companies first reported a position in Lifecore Biomedical in Q2 2023 and held it in 6 quarters.
  • American Century Companies's Lifecore Biomedical position peaked at $432K in Q3 2023.
  • 77 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q4 2024.

Based on American Century Companies's 13F filing for Q4 2024, filed 11 Feb 2025.